Hypercoagulability risk factors in children with minimal change disease and the protective role of protein-C activity

International Urology and Nephrology

Volumn 36, Issue 4, 2004, Pages 599-603

  Öskayin, Nese ^a   Mir, Sevgi ^a   Kavakli, Kaan ^a  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Children; Hypercoagulability; Minimal change disease; Thrombosis

Indexed keywords

ANTIPLASMIN; CHOLESTEROL; D DIMER; FIBRINOGEN; LIPID; LUPUS ANTICOAGULANT; PROTEIN C; PROTHROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEMOSTASIS; HUMAN; HYPERCOAGULABILITY; KIDNEY BIOPSY; LIPID BLOOD LEVEL; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; RISK ASSESSMENT; RISK FACTOR; SCREENING TEST; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; THROMBOCYTE COUNT; THROMBOSIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; NEPHROSIS, LIPOID; PROTEIN C; RISK FACTORS; THROMBOSIS;

EID: 13444259721     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11255-004-0868-3     Document Type: Article

References (14)

1. U Nowak-Gottl K Auberger U Gobel et al. 1996 Inherited defects of the protein C anticoagulant system in childhood thrombo-embolism. Eur J Pediatr 155 921-927
2. Harris R.C. Ismail N. 1994 Extrarenal complications of the nephrotic syndrome Am J Kidney Dis 23 4 477-497
3. C Ponticelli RJ Glassock 1997 Treatment of Primary Glomerulonephritis Oxford University Press Oxford, New York, Tokyo 1-24
4. O Mehls K Andrassy J Koderisch et al. 1987 Hemostasis and thromboembolism in children with nephrotic syndrome: Differences from adults. J Pediatr 110 6 862-867
5. T Jarmolinski J Zachwieja E Bortkiewicz et al. 1996 Thrombo-embolic disease as a complication of nephrotic syndrome in children. Pediatr Pol 71 5 437-441
6. PF Hoyer S Gonda M Barthels et al. 1986 Thromboembolic complications in children with nephrotic syndrome. Risk and incidence. Acta Paediatr Scand 75 5 804-810
7. ND Vaziri P Paule J Toohey et al. 1984 Acquired deficiency and urinary excretion of antithrombin III in nephrotic syndrome. Arch Intern Med 144 9 1802-1803
8. ND Vaziri S Alikhani B Patel et al.1988 Increased levels of protein C activity, protein C concentration, total and free protein S in nephrotic syndrome. Nephron 49 1 20-23
9. D De Mattia R Penza P Giordano et al. 1991 Thromboembolic risk in children with nephrotic syndrome. Haemostasis 21 5 300-304
10. A Citak S Emre A Sirin et al. 2000 Hemostatic problems and thromboembolic complications in nephrotic children. Pediatr Nephrol 14 2 138-142 10.1007/s004670050029 1:STN:280:DC%2BD3c7kvVCjtQ%3D%3D 10684364
11. MM al-Mugerien AM Gader SA al-Rasheed et al.1996 Coagulopathy of childhood nephrotic syndrome - a reappraisal of the role of natural anticoagulants and fibrinolysis. Haemostasis 26 6 304-310
12. T Fujita E Saito H Ohi et al.1992 Lipoprotein (a) predicts the risk of thrombogenic complications in nephrotic syndrome Nephron 61 1 122
13. ND Vaziri et al. 1994 Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome. J Lab Clin Med 124 1 118-124
14. PM Mannucci C Valsecchi B Bottasso et al. 1986 High plasma levels of protein C activity and antigen in the nephrotic syndrome. Thromb Haemost 55 1 31-33